SK1 is known to be highly upregulated in many cancers, such as breast cancer, colon cancer, head and neck cancer, and glioblastoma [11,12,13,14], and its upregulation is associated strongly with poor prognosis and increased cancer metastasis [15,16,17,18,19]. Here, SPHK1 is linked to breast carcinoma.